-
CheckOrphan NewsFlash April 30,…
4/30/2010
CheckOrphan NewsFlash for Tuesday, March 30, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash April 9,…
4/09/2010
CheckOrphan NewsFlash for Friday, April 9, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash April 1,…
4/01/2010
CheckOrphan NewsFlash for Thursday, April 1, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
-
Men 2010: 12th International…
16–18 September, 2010
This two-day meeting will provide a forum for educating basic and clinical…
-
Ribonuclease H2010
20–22 September, 2010
We expect to bring together scientists interested in making as much…
-
Third Annual Ultra Orphan…
27–29 September, 2010
Centric Health Resources Presents Third Annual Ultra Orphan Conference…
-
Brain, Blood and Iron: Joint…
1–2 October, 2010
The overall objectives of this workshop are to (1) define NA and NBIA…
Events
-
Results From Investigator-Sponsored Trials Presented at SSIEM Conference
Friday, September 3, 2010
NOVATO, Calif. -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism (SSIEM), August 31st-In
-
Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
Friday, September 3, 2010
NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced today it will regain full worldwide rights to develop and commercialize rindopepimut (CDX-110), effective November 1, 2010Celldex and Pfizer Vaccines LLC entered into a global development and commercialization agreement in April
-
Merck Serono's Cladribine Tablets for MS Approved in Australia
Friday, September 3, 2010
GENEVA, Switzerland -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1Cladribine Tablets will be registered in A
-
Santhera and Ipsen Enter Into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
Friday, September 3, 2010
Liestal, Switzerland and Paris, France -- Santhera Pharmaceuticals (SIX: SANN) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic al-pha-2 receptor) for territories outside of North America
-
Celator Pharmaceuticals Raises $20 Million in Series D Financing
Friday, September 3, 2010
Princeton, NJ -- Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financingProceeds will support comple
-
Tot With Disorder Is 'the Happiest Kid'
Friday, September 3, 2010
When most people get a cold, they cough and sneeze and sniffle until it goes awayCharlie-Anne Cox can't do that. The 14-month-old's muscles are too weak to cough and the mucus drains into her lungs"Just taking a breath, that's just running a marathon for her, it sounds like at times," says her da
-
Norfolk Baby's Life Hangs by a Thread
Friday, September 3, 2010
A community is rallying to fund comforts and pleasures for a seriously-ill north Norfolk baby whose life could end at any timeLittle Lauren Taylor has the rare chromosome disorder Patau's Syndrome and is blind, partially deaf, needs extra oxygen to breathe, is tube fed, has kidney problems, extra
-
Novartis and Collaborators Discover Novel Antimalarial Drug Candidate
Friday, September 3, 2010
Singapore -- Novartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute M
-
Free Prostate Screenings Offered at Virginia G. Piper Cancer Center
Friday, September 3, 2010
SCOTTSDALE, Ariz. -- Recognizing that early detection can save lives, the Virginia G. Piper Cancer Center at Scottsdale Healthcare is offering free prostate cancer screenings from 8:30 a.m.-12 p.m. on Saturday, Sept. 11Urologists from Scottsdale Healthcare will be available to answer questions and
-
Goddess Hair Extensions Founder Nominated for American Cancer Society Award
Friday, September 3, 2010
SUNNYVALE, Calif. -- Sheila Matechuk, Developer of Goddess Hair Extensions & Replacement, has been nominated for the American Cancer Society's prestigious "Lane Adams Award" honoring individuals who "demonstrate innovative and collaborative approaches to enhancing the quality of life for Mate
